God  our Guide  No-1 in alternative medicine, modern guidelines
 

 
Home
Diagnosis
Treatment
Pathology
Variants
Natural makeup
Diet
IVIG
Celiac Disease Guide
Celiac Disease Info
Celiac D Anatomy
Celiac D Story
Celiac Neurology
Celiac Mystery
Celiac Secrets
Autoimmune diseases

Skin Biosy in CIDP

Takayasu arteritis

Autoimmune self attack

CMT

Sensory CIDP

Inflammatory neuropathy

Multifocal neuropathy

Neuropathy Handbook

Spices

Cholesterol drugs & Bleeding

What is autoimmune

Toxic Baby products

Infants  and women omega-3

 Selenium

Basil

Bay leaves

Eliminate insulin implants

Sugar treatment

Heart FAILURE

Irregular periods

Myasthenia diet

cancer survivor

Tomato as a medicine

New Vaccine

sleep cycles

Asama ul Husna

CIDP-Neuropathy

Liver Flush

 

  

 Sural nerve Biopsy
 

All diseases are autoimmune permanently treatable please read our e-book .

 
Special Google Health Search
 

      
 

Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy

D S M Molenaar,a M Vermeulen,a R de Haanb

a Department of Neurology, b Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam

Correspondence to: Dr DSM Molenaar, Department of Neurology (H2-214), Academic Medical Center, PO Box 22700, 1100 DE Amsterdam, The Netherlands. Telephone 0031 20 5663546; fax 0031 20 6971438;

Received 19 May 1997 and in revised form 22 July 1997; Accepted 29 July 1997

 Abstract

OBJECTIVE---To investigate the additional diagnostic value of sural nerve biopsy of 64 patients in whom chronic inflammatory demyelinating polyneuropathy (CIDP) was considered, as sural nerve biopsy is recommended in the research criteria of an ad hoc subcommittee to diagnose CIDP.
METHODS---Firstly, the additional diagnostic value of sural nerve biopsy was analysed with multivariate logistic re- gression. Six clinical features (remitting course, symmetric sensorimotor neuropathy in arms and legs, areflexia, raised CSF protein concentration, nerve conduction studies consistent with demyelination, and absence of comorbidity or relevant laboratory abnormalities) were entered into a logistic model. Afterwards, all significant features identified from this model, as well as the results of sural nerve biopsy were forced into a second logistic model. Secondly, the diagnostic performance of a neurologist experienced in diagnosis of peripheral nerve disorders was studied by receiver operating characteristics (ROC) curve analysis.
RESULTS---The results of the first logistic analysis showed that CSF protein concentration >1 g/l (odds ratio (OR)=38.5) and neurophysiological studies consistent with demyelination (OR=51.7) were strong predictors of CIDP. When forcing the significant features and the sural nerve biopsy data into the model, an independent predictive value of sural nerve biopsy could not be found. The neurologist was able to discriminate patients with and without CIDP (area under the curve (AUC)=0.95). His diagnostic performance did not improve significantly by offering him the results of sural nerve biopsy.
CONCLUSION---Any additional diagnostic value of sural nerve biopsy in the diagnosis of CIDP could not be shown.
(J Neurol Neurosurg Psychiatry 1998;64:84-89)

Keywords: chronic inflammatory demyelinating polyneuropathy;  sural nerve biopsy


 
    Introduction

Sural nerve biopsy is considered to be a valuable method for establishing the cause of peripheral neuropathies in specific circumstances, if it is evaluated by a neuropathologist experienced in modern techniques. It is indicated in a few patients with peripheral neuropathy and should be done only after careful clinical, laboratory, and neurophysiological evaluation.Whether suspected chronic inflammatory demyelinating polyneuropathy (CIDP) is an indication for sural nerve biopsy studies remains inconclusive from reports in the literature. Argov et al, for instance, suggest that sural nerve biopsy should be reserved for patients with a clinical picture of polyneuropathy and electrodiagnostic criteria suggestive of demyelination. Asbury, however, recommends the use of sural nerve biopsy only in cases of a clinical picture of mononeuritis multiplex, enlarged nerves at palpation, or for establishing diagnosis in genetically determined paediatric disorders. Sural nerve biopsy studies have been reported in several series of patients with CIDP. The abnormalities found are often not specific for CIDP On the other hand, sural nerve biopsy is a requisite for diagnosis of "definite" CIDP according to the research criteria for diagnosis of CIDP of the ad hoc subcommittee, published in 1990.

Other tests to diagnose CIDP include lumbar puncture, withdrawal of blood, and neurophysiological tests. Sural nerve biopsy is the most invasive procedure of all these procedures and should be considered after the results of the other tests are known. However, little is known about the diagnostic properties of sural nerve biopsy in CIDP. Therefore, the objectives of this study were (1) to investigate the objective additional diagnostic value of sural nerve biopsy in CIDP, given the results of the clinical picture, and laboratory and neurophysiological tests, and (2) to assess to what extent the diagnostic performance of an experienced neurologist was influenced by the results of sural nerve biopsy.


Please continue to sural nerve biopsy on next page